This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (56)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • HIV/AIDS  • Substance Abuse/ Alcoholism  • Drug Therapy  • Adherence  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

Renslow Sherer, MD

JAMA. 1998;280:567-568.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The intertwined epidemics of human immunodeficiency virus (HIV) infection and chemical dependency continue to be a challenge for optimal medical care delivery in the era of potent antiretroviral therapy. In this issue of JAMA, Celentano et al¹ report a cross-sectional survey in 404 injecting drug users (IDUs) with HIV infection in Baltimore, Md, from mid-1996 to mid-1997 in which only 57 (14%) of 404 patients reported receiving potent antiretroviral therapy. Sixty-three percent of patients reported receiving no (49%) or inadequate (14%) therapy. Active injecting drug use, lack of advanced disease (acquired immunodeficiency syndrome [AIDS]), not being in a substance abuse treatment program, and not having a usual source of primary care or health insurance were associated with not receiving therapy.

In a second study in this issue, Strathdee et al² report similar findings among 177 IDUs in Vancouver, British Columbia, during a similar period but in . . . [Full Text of this Article]

From the Cook County HIV Center, Division of Infectious Disease, Department of Medicine, Cook County Hospital and Rush Medical College, Chicago, Ill.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy
Lucas et al.
Am J Epidemiol 2006;163:412-420.
ABSTRACT | FULL TEXT  

Delivery of HIV Prevention Counseling by Physicians at HIV Medical Care Settings in 4 US Cities
Metsch et al.
AJPH 2004;94:1186-1192.
ABSTRACT | FULL TEXT  

HIV viral suppression in the era of antiretroviral therapy
Thaker and Snow
Postgrad. Med. J. 2003;79:36-42.
ABSTRACT | FULL TEXT  

Guidelines for Using Antiretroviral Agents among HIV-Infected Adults and Adolescents: The Panel on Clinical Practices for Treatment of HIV
Dybul et al.
ANN INTERN MED 2002;137:381-433.
ABSTRACT | FULL TEXT  

Marked Declines in Human Immunodeficiency Virus-Related Mortality in Chicago in Women, African Americans, Hispanics, Young Adults, and Injection Drug Users, From 1995 Through 1997
Whitman et al.
Arch Intern Med 2000;160:365-369.
ABSTRACT | FULL TEXT  

AIDS-Related Stigma and Attitudes toward Injecting Drug users among Black and White Americans
CAPITANIO and HEREK
American Behavioral Scientist 1999;42:1148-1161.
ABSTRACT